Literature DB >> 21157041

Bcl3 prevents acute inflammatory lung injury in mice by restraining emergency granulopoiesis.

Daniel Kreisel1, Seiichiro Sugimoto, Jeremy Tietjens, Jihong Zhu, Sumiharu Yamamoto, Alexander S Krupnick, Ruaidhri J Carmody, Andrew E Gelman.   

Abstract

Granulocytes are pivotal regulators of tissue injury. However, the transcriptional mechanisms that regulate granulopoiesis under inflammatory conditions are poorly understood. Here we show that the transcriptional coregulator B cell leukemia/lymphoma 3 (Bcl3) limits granulopoiesis under emergency (i.e., inflammatory) conditions, but not homeostatic conditions. Treatment of mouse myeloid progenitors with G-CSF--serum concentrations of which rise under inflammatory conditions--rapidly increased Bcl3 transcript accumulation in a STAT3-dependent manner. Bcl3-deficient myeloid progenitors demonstrated an enhanced capacity to proliferate and differentiate into granulocytes following G-CSF stimulation, whereas the accumulation of Bcl3 protein attenuated granulopoiesis in an NF-κB p50-dependent manner. In a clinically relevant model of transplant-mediated lung ischemia reperfusion injury, expression of Bcl3 in recipients inhibited emergency granulopoiesis and limited acute graft damage. These data demonstrate a critical role for Bcl3 in regulating emergency granulopoiesis and suggest that targeting the differentiation of myeloid progenitors may be a therapeutic strategy for preventing inflammatory lung injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21157041      PMCID: PMC3007142          DOI: 10.1172/JCI42596

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  67 in total

1.  Expression of the Bcl-3 proto-oncogene suppresses p53 activation.

Authors:  David Kashatus; Patricia Cogswell; Albert S Baldwin
Journal:  Genes Dev       Date:  2005-12-29       Impact factor: 11.361

2.  C/EBPbeta is required for 'emergency' granulopoiesis.

Authors:  Hideyo Hirai; Pu Zhang; Tajhal Dayaram; Christopher J Hetherington; Shin-ichi Mizuno; Jiro Imanishi; Koichi Akashi; Daniel G Tenen
Journal:  Nat Immunol       Date:  2006-06-04       Impact factor: 25.606

3.  Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration.

Authors:  A C Ward; M H Hermans; L Smith; Y M van Aesch; A M Schelen; C Antonissen; I P Touw
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

4.  CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury.

Authors:  John A Belperio; Michael P Keane; Marie D Burdick; Brigitte N Gomperts; Ying Ying Xue; Kurt Hong; Javier Mestas; David Zisman; Abbas Ardehali; Rajan Saggar; Joseph P Lynch; David J Ross; Robert M Strieter
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

5.  The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.

Authors:  R Dechend; F Hirano; K Lehmann; V Heissmeyer; S Ansieau; F G Wulczyn; C Scheidereit; A Leutz
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

6.  Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis.

Authors:  Florencia McAllister; Adam Henry; James L Kreindler; Patricia J Dubin; Lauren Ulrich; Chad Steele; Jonathan D Finder; Joseph M Pilewski; Beatriz M Carreno; Samuel J Goldman; Jaana Pirhonen; Jay K Kolls
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

7.  Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha.

Authors:  Pu Zhang; Junko Iwasaki-Arai; Hiromi Iwasaki; Maris L Fenyus; Tajhal Dayaram; Bronwyn M Owens; Hirokazu Shigematsu; Elena Levantini; Claudia S Huettner; Julie A Lekstrom-Himes; Koichi Akashi; Daniel G Tenen
Journal:  Immunity       Date:  2004-12       Impact factor: 31.745

8.  Interleukin-6 regulation of direct lung ischemia reperfusion injury.

Authors:  Alexander S Farivar; Heather E Merry; Mauricio J Fica-Delgado; Anton S McCourtie; Brendan C Mackinnon-Patterson; Michael S Mulligan
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

9.  Characterization of the role of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit in the activation of JAK2 and STAT5.

Authors:  S E Doyle; J C Gasson
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

10.  Cytoplasmic domains of the human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor beta chain (hbetac) responsible for human GM-CSF-induced myeloid cell differentiation.

Authors:  T Matsuguchi; M B Lilly; A S Kraft
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

View more
  62 in total

1.  The oncoprotein and transcriptional regulator Bcl-3 governs plasticity and pathogenicity of autoimmune T cells.

Authors:  Wanhu Tang; Hongshan Wang; Estefania Claudio; Ilaria Tassi; Hye-lin Ha; Sun Saret; Ulrich Siebenlist
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Alternative nuclear functions for NF-κB family members.

Authors:  Lluís Espinosa; Anna Bigas; Maria Carmen Mulero
Journal:  Am J Cancer Res       Date:  2011-02-16       Impact factor: 6.166

3.  Five-year update on the mouse model of orthotopic lung transplantation: Scientific uses, tricks of the trade, and tips for success.

Authors:  Xue Lin; Wenjun Li; Jiaming Lai; Mikio Okazaki; Seiichiro Sugimoto; Sumiharu Yamamoto; Xingan Wang; Andrew E Gelman; Daniel Kreisel; Alexander Sasha Krupnick
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

Review 4.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

Review 5.  Ischemia and reperfusion--from mechanism to translation.

Authors:  Holger K Eltzschig; Tobias Eckle
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

6.  Donor pulmonary intravascular nonclassical monocytes recruit recipient neutrophils and mediate primary lung allograft dysfunction.

Authors:  Zhikun Zheng; Stephen Chiu; Mahzad Akbarpour; Haiying Sun; Paul A Reyfman; Kishore R Anekalla; Hiam Abdala-Valencia; Daphne Edgren; Wenjun Li; Daniel Kreisel; Farida V Korobova; Ramiro Fernandez; Alexandra McQuattie-Pimentel; Zheng J Zhang; Harris Perlman; Alexander V Misharin; G R Scott Budinger; Ankit Bharat
Journal:  Sci Transl Med       Date:  2017-06-14       Impact factor: 17.956

7.  Noninvasive Imaging of CCR2+ Cells in Ischemia-Reperfusion Injury After Lung Transplantation.

Authors:  Y Liu; W Li; H P Luehmann; Y Zhao; L Detering; D H Sultan; H-M Hsiao; A S Krupnick; A E Gelman; C Combadiere; R J Gropler; S L Brody; D Kreisel
Journal:  Am J Transplant       Date:  2016-07-14       Impact factor: 8.086

8.  DAP12 expression in lung macrophages mediates ischemia/reperfusion injury by promoting neutrophil extravasation.

Authors:  Jessica H Spahn; Wenjun Li; Alejandro C Bribriesco; Jie Liu; Hua Shen; Aida Ibricevic; Jie-Hong Pan; Bernd H Zinselmeyer; Steven L Brody; Daniel R Goldstein; Alexander S Krupnick; Andrew E Gelman; Mark J Miller; Daniel Kreisel
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

9.  Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation.

Authors:  David M Sayah; Beñat Mallavia; Fengchun Liu; Guadalupe Ortiz-Muñoz; Axelle Caudrillier; Ariss DerHovanessian; David J Ross; Joseph P Lynch; Rajan Saggar; Abbas Ardehali; Lorraine B Ware; Jason D Christie; John A Belperio; Mark R Looney
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

Review 10.  Innate immunity and organ transplantation: focus on lung transplantation.

Authors:  Daniel Kreisel; Daniel R Goldstein
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.